To functionally confirm the relationship between HIF2α and the RNASET2 gene, we treated ccRCC cells with a HIF2α inhibitor PT2385, which inhibits the interaction between HIF2α and ARNT (also known as HIFβ) thus blocking the activity of HIF2α. This evidence concerns the gene RNASET2 and nonpapillary renal cell carcinoma.